Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000129914 | SCV000184732 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-05-22 | criteria provided, single submitter | clinical testing | The p.V1144G variant (also known as c.3431T>G), located in coding exon 10 of the BRCA2 gene, results from a T to G substitution at nucleotide position 3431. The valine at codon 1144 is replaced by glycine, an amino acid with dissimilar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV001703943 | SCV000210590 | likely benign | not provided | 2019-10-10 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a benign effect; This variant is associated with the following publications: (PMID: 31131967) |
Counsyl | RCV000083098 | SCV000489470 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2016-10-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000129914 | SCV000903237 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001434940 | SCV001637758 | likely benign | Hereditary breast ovarian cancer syndrome | 2025-01-19 | criteria provided, single submitter | clinical testing | |
University of Washington Department of Laboratory Medicine, |
RCV000129914 | SCV003851953 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |
All of Us Research Program, |
RCV000083098 | SCV004845156 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2023-07-13 | criteria provided, single submitter | clinical testing | |
Sharing Clinical Reports Project |
RCV000083098 | SCV000115172 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2012-05-01 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000083098 | SCV000146232 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | no assertion criteria provided | clinical testing |